Baidu
map

聚焦|原料药价格暴涨,扑尔敏药价从400元涨到23300元!有药企已停产!

2018-08-08 甘霖 整理 医师报

近日,辽宁省药品和医用耗材集中采购网发布一则预警通知,涉及81种不能正常供应配送的药品,其中12个药品由于原料、企业生产线改造等原因造成产能不足;13个药品由于采购不到原料而停产;17个药品以原料药价格上涨、中标价格低为由,不能正常供应。


近日,辽宁省药品和医用耗材集中采购网发布一则预警通知,涉及81种不能正常供应配送的药品,其中12个药品由于原料、企业生产线改造等原因造成产能不足;13个药品由于采购不到原料而停产;17个药品以原料药价格上涨、中标价格低为由,不能正常供应。

不久前就有药企采购、销售人员向媒体表示,由于原料药被经销商垄断,用于治疗鼻炎、皮肤黏膜过敏等的马来酸氯苯那敏(扑尔敏)原料药一个月涨了58倍,从400元/kg涨到23300元/kg,这或涉及1000亿元规模成品药市场的正常生产与销售。

原料药价格暴涨,有药企已停产

“网上传的都是真的,扑尔敏原料药价格就是涨得这么夸张。”广东某药企老板吴阳(化名)无奈地记者表示,旗下正好有几个马来酸氯苯那敏的生产批文,“从去年10月份起陆续停产,到现在相关的批文全部闲置了。”吴阳向记者表示,“不是不想生产,是我们压根拿不到原料药了。”

据报道,马来酸氯苯那敏价格从400元/kg涨到了23300元/kg,足足涨了58倍!而就在今年7月份,还有媒体报道称,某大型药企的采购人员透露“马来酸氯苯那敏原料药报价从去年底260~280元/公斤涨至1.5万元/公斤,足足上涨了50倍”,短短一个月,价格从1.5万又涨至2.3万,可见马来酸氯苯那敏在全国范围内涨价态势之猛。

实际上,虽然马来酸氯苯那敏原料药是小品种,但对应的成品药都是抗过敏、抗感冒的常见药。粗略估算,背后涉及几百亿、上千亿元的药品市场容量。记者从原CFDA数据库查阅发现,目前以马来酸氯苯那敏直接命名的药品批文有421个,含马来酸氯苯那敏成本的药品批文则有超过2100个。

不过,像吴阳那样,停止含扑尔敏成分的药品生产的企业或不在少数。“对于企业而言,利润少、成本大,生产也不赚钱,有批文不如闲置。” 另一家同样持有生产批文的某药企广州区域负责人李立(化名)向记者表示。

原料药批文少,经销商容易抱团提价

至于扑尔敏原料药为何会大幅涨价?多位业内人士均表示,跟“经销商控制”确实有很大关系。

CFDA数据库显示,拥有扑尔敏原料药批文的企业一共有7家,6家国内企业、一家进口企业。但据了解,实际持续保持生产的目前只有两三家药企,进口企业占比更很小。去年年底,其中一家企业还因为违规省被药监局收回了GMP证书。

“涨价一般来说受很多因素影响,环保因素、垄断因素,但这次垄断的原因比较大。”李立表示,“就像’炒房团’一样,一旦经销商联合起来抱团,这些药的价格就会被炒上来。”

由于审批严格,取得原料药生产资质的药厂并不多。国家发改委价监局副局长李青曾介绍,我国1500种化学原料药中,50种原料药仅一家企业取得审批资格可以生产,44种原料药仅两家企业可以生产,40种原料药仅3家可以生产。

而考虑到污染压力大、盈利空间小,真正生产的药厂数量可能更少。从近年公布的原料药垄断案来看,被垄断原料药的获批生产厂家多为个位数,实际投产的往往仅有2~3家。

实际上,这一轮原料药的涨价不仅仅限于扑尔敏。公开资料显示,维生素B6价格从每公斤150元上涨到980元,葡甲铵价格由每公斤210元上涨到8000元……原料药价格翻倍涨让药企“叫苦不迭”。

某药企董事长李振江曾公开指出“垄断是这轮原料药涨价的特点,比如一家原料药企业收购其他同类企业,然后涨价,或者联合其他家企业一起涨价。

业内人士称,原料涨幅过快,药企要么停产,要么涨价,最终都是老百姓买单。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1957586, encodeId=c880195e586e1, content=<a href='/topic/show?id=8aef54609d5' target=_blank style='color:#2F92EE;'>#扑尔敏#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54609, encryptionId=8aef54609d5, topicName=扑尔敏)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/1103841572/656F31B644588474D1C46903A7F84373/100, createdBy=4e842500199, createdName=ms24272190615788285182, createdTime=Sun Oct 28 10:40:00 CST 2018, time=2018-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1382920, encodeId=43a1138292068, content=<a href='/topic/show?id=99328e292cd' target=_blank style='color:#2F92EE;'>#药价#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87292, encryptionId=99328e292cd, topicName=药价)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4193478, createdName=wgx306, createdTime=Fri Aug 10 10:40:00 CST 2018, time=2018-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1497133, encodeId=5de0149e133aa, content=<a href='/topic/show?id=30003e186fa' target=_blank style='color:#2F92EE;'>#原料药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=144, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37186, encryptionId=30003e186fa, topicName=原料药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8d4d9304903, createdName=slcumt, createdTime=Fri Aug 10 10:40:00 CST 2018, time=2018-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=337378, encodeId=7c0c33e3781c, content=学习一下,谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/23/2f51002e1349ccda5be11c1eea1e1e60.jpg, createdBy=a22097948, createdName=天地飞扬, createdTime=Wed Aug 08 22:22:17 CST 2018, time=2018-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=337350, encodeId=cc1133e3504a, content=基药都给垄断了, beContent=null, objectType=article, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/2EVCwc9WmQS6ec99H2TX8ejmR40xYjwrIcrqjAnibV36aicL1sLxc21rhpZnqTOxk33HP44iayEwo6qYXqgZvdRtA/132, createdBy=d0d01573846, createdName=329523732, createdTime=Wed Aug 08 19:53:14 CST 2018, time=2018-08-08, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1957586, encodeId=c880195e586e1, content=<a href='/topic/show?id=8aef54609d5' target=_blank style='color:#2F92EE;'>#扑尔敏#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54609, encryptionId=8aef54609d5, topicName=扑尔敏)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/1103841572/656F31B644588474D1C46903A7F84373/100, createdBy=4e842500199, createdName=ms24272190615788285182, createdTime=Sun Oct 28 10:40:00 CST 2018, time=2018-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1382920, encodeId=43a1138292068, content=<a href='/topic/show?id=99328e292cd' target=_blank style='color:#2F92EE;'>#药价#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87292, encryptionId=99328e292cd, topicName=药价)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4193478, createdName=wgx306, createdTime=Fri Aug 10 10:40:00 CST 2018, time=2018-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1497133, encodeId=5de0149e133aa, content=<a href='/topic/show?id=30003e186fa' target=_blank style='color:#2F92EE;'>#原料药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=144, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37186, encryptionId=30003e186fa, topicName=原料药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8d4d9304903, createdName=slcumt, createdTime=Fri Aug 10 10:40:00 CST 2018, time=2018-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=337378, encodeId=7c0c33e3781c, content=学习一下,谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/23/2f51002e1349ccda5be11c1eea1e1e60.jpg, createdBy=a22097948, createdName=天地飞扬, createdTime=Wed Aug 08 22:22:17 CST 2018, time=2018-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=337350, encodeId=cc1133e3504a, content=基药都给垄断了, beContent=null, objectType=article, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/2EVCwc9WmQS6ec99H2TX8ejmR40xYjwrIcrqjAnibV36aicL1sLxc21rhpZnqTOxk33HP44iayEwo6qYXqgZvdRtA/132, createdBy=d0d01573846, createdName=329523732, createdTime=Wed Aug 08 19:53:14 CST 2018, time=2018-08-08, status=1, ipAttribution=)]
    2018-08-10 wgx306
  3. [GetPortalCommentsPageByObjectIdResponse(id=1957586, encodeId=c880195e586e1, content=<a href='/topic/show?id=8aef54609d5' target=_blank style='color:#2F92EE;'>#扑尔敏#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54609, encryptionId=8aef54609d5, topicName=扑尔敏)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/1103841572/656F31B644588474D1C46903A7F84373/100, createdBy=4e842500199, createdName=ms24272190615788285182, createdTime=Sun Oct 28 10:40:00 CST 2018, time=2018-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1382920, encodeId=43a1138292068, content=<a href='/topic/show?id=99328e292cd' target=_blank style='color:#2F92EE;'>#药价#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87292, encryptionId=99328e292cd, topicName=药价)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4193478, createdName=wgx306, createdTime=Fri Aug 10 10:40:00 CST 2018, time=2018-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1497133, encodeId=5de0149e133aa, content=<a href='/topic/show?id=30003e186fa' target=_blank style='color:#2F92EE;'>#原料药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=144, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37186, encryptionId=30003e186fa, topicName=原料药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8d4d9304903, createdName=slcumt, createdTime=Fri Aug 10 10:40:00 CST 2018, time=2018-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=337378, encodeId=7c0c33e3781c, content=学习一下,谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/23/2f51002e1349ccda5be11c1eea1e1e60.jpg, createdBy=a22097948, createdName=天地飞扬, createdTime=Wed Aug 08 22:22:17 CST 2018, time=2018-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=337350, encodeId=cc1133e3504a, content=基药都给垄断了, beContent=null, objectType=article, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/2EVCwc9WmQS6ec99H2TX8ejmR40xYjwrIcrqjAnibV36aicL1sLxc21rhpZnqTOxk33HP44iayEwo6qYXqgZvdRtA/132, createdBy=d0d01573846, createdName=329523732, createdTime=Wed Aug 08 19:53:14 CST 2018, time=2018-08-08, status=1, ipAttribution=)]
    2018-08-10 slcumt
  4. [GetPortalCommentsPageByObjectIdResponse(id=1957586, encodeId=c880195e586e1, content=<a href='/topic/show?id=8aef54609d5' target=_blank style='color:#2F92EE;'>#扑尔敏#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54609, encryptionId=8aef54609d5, topicName=扑尔敏)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/1103841572/656F31B644588474D1C46903A7F84373/100, createdBy=4e842500199, createdName=ms24272190615788285182, createdTime=Sun Oct 28 10:40:00 CST 2018, time=2018-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1382920, encodeId=43a1138292068, content=<a href='/topic/show?id=99328e292cd' target=_blank style='color:#2F92EE;'>#药价#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87292, encryptionId=99328e292cd, topicName=药价)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4193478, createdName=wgx306, createdTime=Fri Aug 10 10:40:00 CST 2018, time=2018-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1497133, encodeId=5de0149e133aa, content=<a href='/topic/show?id=30003e186fa' target=_blank style='color:#2F92EE;'>#原料药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=144, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37186, encryptionId=30003e186fa, topicName=原料药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8d4d9304903, createdName=slcumt, createdTime=Fri Aug 10 10:40:00 CST 2018, time=2018-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=337378, encodeId=7c0c33e3781c, content=学习一下,谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/23/2f51002e1349ccda5be11c1eea1e1e60.jpg, createdBy=a22097948, createdName=天地飞扬, createdTime=Wed Aug 08 22:22:17 CST 2018, time=2018-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=337350, encodeId=cc1133e3504a, content=基药都给垄断了, beContent=null, objectType=article, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/2EVCwc9WmQS6ec99H2TX8ejmR40xYjwrIcrqjAnibV36aicL1sLxc21rhpZnqTOxk33HP44iayEwo6qYXqgZvdRtA/132, createdBy=d0d01573846, createdName=329523732, createdTime=Wed Aug 08 19:53:14 CST 2018, time=2018-08-08, status=1, ipAttribution=)]
    2018-08-08 天地飞扬

    学习一下,谢谢分享!

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1957586, encodeId=c880195e586e1, content=<a href='/topic/show?id=8aef54609d5' target=_blank style='color:#2F92EE;'>#扑尔敏#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54609, encryptionId=8aef54609d5, topicName=扑尔敏)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/1103841572/656F31B644588474D1C46903A7F84373/100, createdBy=4e842500199, createdName=ms24272190615788285182, createdTime=Sun Oct 28 10:40:00 CST 2018, time=2018-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1382920, encodeId=43a1138292068, content=<a href='/topic/show?id=99328e292cd' target=_blank style='color:#2F92EE;'>#药价#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87292, encryptionId=99328e292cd, topicName=药价)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4193478, createdName=wgx306, createdTime=Fri Aug 10 10:40:00 CST 2018, time=2018-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1497133, encodeId=5de0149e133aa, content=<a href='/topic/show?id=30003e186fa' target=_blank style='color:#2F92EE;'>#原料药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=144, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37186, encryptionId=30003e186fa, topicName=原料药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8d4d9304903, createdName=slcumt, createdTime=Fri Aug 10 10:40:00 CST 2018, time=2018-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=337378, encodeId=7c0c33e3781c, content=学习一下,谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/23/2f51002e1349ccda5be11c1eea1e1e60.jpg, createdBy=a22097948, createdName=天地飞扬, createdTime=Wed Aug 08 22:22:17 CST 2018, time=2018-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=337350, encodeId=cc1133e3504a, content=基药都给垄断了, beContent=null, objectType=article, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/2EVCwc9WmQS6ec99H2TX8ejmR40xYjwrIcrqjAnibV36aicL1sLxc21rhpZnqTOxk33HP44iayEwo6qYXqgZvdRtA/132, createdBy=d0d01573846, createdName=329523732, createdTime=Wed Aug 08 19:53:14 CST 2018, time=2018-08-08, status=1, ipAttribution=)]
    2018-08-08 329523732

    基药都给垄断了

    0

相关资讯

打通药品供应“肠梗阻”

保证药品的安全供应是关系人民群众健康的重大民生问题,也是提高医疗服务质量的有效途径。近年来,保证常用廉价药品的正常供应、加快创新药物的临床使用,一直是社会高度关注的话题。全国两会期间,不少医药卫生界的代表委员针对加强药品供应保障提出了自己的观点。

一文读懂化药、中药、生物药、原料药、商业后三季发展趋势

受益于国家政策的影响,自2016年起,上市公司营收增速整体呈上升趋势,这种趋势显示在数据中:2017年A股271家医药上市公司合计实现营收1.17万亿元,同比增长18.52%;2018年一季度合计实现营收3269.7亿元,同比增长24.57%。这是因为两票制实行后低开转高开在报表端增厚了营收,另一方面创新药的发展、流通和服务端的扩张、零售端的增速加快为行业发展注入动力。而随着较多公司产品结构

国务院环保整治出重拳 70%原料药企将遭淘汰

8月7日,党中央、国务院决定开启第四批中央环境保护督查工作。据环保网官方消息称,已经组建8个中央环境保护督察组,分别对吉林、浙江、山东、海南、四川、西藏、青海、新疆(含兵团)开展督察进驻工作,实现对全国各省(区、市)督察全覆盖。此次督察以迅雷不及掩耳之势展开,在今天,中央第五环境保护督察组已经率先进驻四川展开督察工作。根据安排,8个中央环保督察组将于接下来的一周陆续进入各省市。

发改委:短缺药品和原料药经营者不得操纵市场价格

国家发改委将持续调查、评估短缺药品和原料药市场总体竞争状况,加大执法力度,曝光典型案例,回应社会关切。

5分钟密谋,原料药全国涨价5倍!

国家发改委查垄断,药企老板在两会上怒斥涨价;原料药产生的排浪,拍打药企痛不欲生,引起官方震动。但鲜为人知的是,掀起这场波澜的,可能只是一个饭局、一个茶会。甚至只需要5分钟。

总局再禁一种印度进口药

11月8日,国家食药监总局发布《关于暂停销售使用印度Enal Drugs Pvt.Ltd.雷贝拉唑钠原料药的公告(2017年第133号)》。

Baidu
map
Baidu
map
Baidu
map